PHF19 inhibition as a therapeutic target in Multiple Myeloma

Epigenetic deregulation is increasingly recognized as a contributing pathological factor in multiple myeloma (MM). In particular tri-methylation of H3 lysine 27 (H3K27me3), which is catalyzed by PHD finger protein 19 (PHF19), a subunit of the Polycomb Repressive Complex 2 (PRC2), has recently shown...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Curr Res Transl Med
Main Authors: Schinke, Carolina D., Bird, Jordan T., Qu, Pingping, Yaccoby, Shmuel, Lyzogubov, Valeriy V, Shelton, Randal, Ling, Wen, Boyle, Eileen M, Deshpande, Sharyu, Byrum, Stephanie D., Washam, Charity, Mackintosh, Samuel, Stephens, Owen, Thanendrarajan, Sharmilan, Zangari, Maurizio, Shaughnessy, John, Zhan, Fenghuang, Barlogie, Bart, van Rhee, Frits, Walker, Brian A
Formato: Artigo
Idioma:Inglês
Publicado: 2021
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8316274/
https://ncbi.nlm.nih.gov/pubmed/33894670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.retram.2021.103290
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares